NPS PHARMACEUTICALS INC SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
NPS PHARMACEUTICALS INC reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction of $6.12 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesDeductions · last filed 2015-02-18
- NPS PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2014 was $6.12M, a 369.33% increase from fiscal 2013.
- NPS PHARMACEUTICALS INC sec schedule, 12-09, valuation allowances and reserves, deduction for fiscal 2013 was $1.30M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction 12 month |
|---|---|
| 2014-12-31 | $6.12M 10-K · filed 2015-02-18 |
| 2013-12-31 | $1.30M 10-K · filed 2015-02-18 |